In addition, Tada et al. recently reported that serum Lp(a) was elevated in patients with familial hypercholesterolemia caused by PCSK9 gain-of-function mutations to the same level as that in familial hypercholesterolemia caused by LDLR mutations [30]. This evidence concerns the gene PCSK9 and familial hypercholesterolemia.